SOLUTIONS 30 SIGNS A €210 MILLION CONTRACT WITH TIM (TELECOM ITALIA)
This contract will be operated by an alliance led by Solutions 30 who will provide 60% of the services.
TIM (Telecom Italia) has entrusted Solutions 30, with deploying its FTTH network in Piedmont and Aosta Valley. Worth €210 million over 5 years, this contract is part of the vast project to create a single fiber-optic network in Italy.
In September 2020, TIM had launched a series of regional calls for tenders to select the service providers that will deploy its future FTTH network. Solutions 30 was selected as the partner in Piedmont and Aosta Valley and has been awarded a €210 million contract effective today and lasting 5 years. In order to operate this contract in the most efficient way, Solutions 30 has created an alliance with Elecnor, one of the leading Spanish industrial groups in the infrastructure, renewable energy, and new technology sectors. Within the framework of this alliance, Solutions 30 will provide and invoice 60% of the services.
This contract opens up a new development phase for Solutions 30 in Italy.
“We would like to thank Telecom Italia for their trust and are very pleased to partner with them on such a key project in Italy-both in terms of its scope and strategic nature for the country,” states Ruggero Fortis, CEO of Solutions 30 Italy. “Solutions 30’s expertise in deploying fiber optics, gained on the French and Spanish markets, bolstered our candidacy and demonstrated our ability to serve our customers efficiently. At present, we are ready to embark on the implementation phase. ”
About Solutions 30 SE
The Solutions 30 group is the European leader in solutions for new technologies. Its mission is to make the technological developments that are transforming our daily lives accessible to everyone, individuals and businesses alike. Yesterday, it was computers and the Internet. Today, it’s digital technology. Tomorrow, it will be technologies that make the world even more interconnected in real time. With more than 30 million call-outs carried out since it was founded and a network of more than 11,000 local technicians, Solutions 30 currently covers all of France, Italy, Germany, the Netherlands, Belgium, Luxembourg, the Iberian Peninsula, Poland, and the United Kingdom. The share capital of Solutions 30 SE consists of 107,127,984 shares, equal to the number of theoretical votes that can be exercised.
Solutions 30 SE is listed on the Euronext Paris exchange (ISIN FR0013379484- code S30). Indexes: MSCI Europe Small Cap | Tech40 | CAC PME | SBF120 | CAC Mid 60. Visit our website for more information: www.solutions30.com
Analysts/investors: Nathalie Boumendil | Tel: +33 6 85 82 41 95 | email@example.com
Press: Samuel Beaupain | Tel: + 352 2 777 4210 | firstname.lastname@example.org
Image 7: Leslie Jung | +44 7818 641803 | email@example.com
Flore Larger | +33 6 33 13 41 50 | firstname.lastname@example.org
Charlotte Le Barbier | +33 6 78 37 27 60 | email@example.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Thin Film Electronics ASA26.1.2021 18:03:44 CET | Press release
Thin Film Electronics ASA - Registration of Share Capital Increase
IPSOS26.1.2021 18:02:44 CET | Press release
Ipsos consolidates its Out-of-home measurement leadership with the acquisition of MGE Data
SOLUTIONS 3026.1.2021 18:01:44 CET | Press release
Solutions 30 : REMARKABLE REVENUE GROWTH IN 2020
EXEL INDUSTRIES26.1.2021 18:01:33 CET | Press release
Exel Industries :First quarter 2020-2021 revenue : A promising first quarter: 19% growth
NACON26.1.2021 17:46:33 CET | Press release
PRESS RELEASE: NACON AND DAEDALIC ENTERTAINMENT ARE FORMING A FELLOWSHIP TO PUBLISH AND DISTRIBUTE THE HIGHLY-ANTICIPATED THE LORD OF THE RINGS: GOLLUM
NTG Nordic Transport Group A/S26.1.2021 17:16:21 CET | Press release
Transactions in connection with share buyback program
Junshi Biosciences26.1.2021 16:37:10 CET | Press release
New data show treatment with etesevimab (JS016) and bamlanivimab together reduced risk of COVID-19 hospitalizations and death by 70 percent
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom